SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Margaret L Gourlay, John S Preisser, Li-Yung Lui, Jane A Cauley, Kristine E Ensrud, BMD screening in older women: Initial measurement and testing interval, Journal of Bone and Mineral Research, 2012, 27, 4
  2. 2
    J. Sanfélix-Genovés, G. Sanfélix-Gimeno, S. Peiró, I. Hurtado, C. Fluixà, A. Fuertes, J. C. Campos, V. Giner, C. Baixauli, Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort, Osteoporosis International, 2012,

    CrossRef

  3. 3
    Clifford Rosen, Goldman's Cecil Medicine, 2012,

    CrossRef

  4. 4
    W. D. Leslie, S. Morin, L. M. Lix, H. Johansson, A. Oden, E. McCloskey, J. A. Kanis, Fracture risk assessment without bone density measurement in routine clinical practice, Osteoporosis International, 2011, 23, 1, 75

    CrossRef

  5. 5
    B. Dawson-Hughes, A. C. Looker, A. N. A. Tosteson, H. Johansson, J. A. Kanis, L. J. Melton, The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005–2008, Osteoporosis International, 2011, 23, 3, 811

    CrossRef

  6. 6
    Meghan G Donaldson, Peggy M Cawthon, Lily Y Lui, John T Schousboe, Kristine E Ensrud, Brent C Taylor, Jane A Cauley, Teresa A Hillier, Thuy T Dam, Jeff R Curtis, Dennis M Black, Douglas C Bauer, Eric S Orwoll, Steven R Cummings, Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US national osteoporosis foundation guidelines, Journal of Bone and Mineral Research, 2010, 25, 7